•  
  •  
  •  
  •  

2026-05-23 13:19:23

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Bajaj Broking Weekly FII and DII Commentary for 23rd May 2026
  • TCC Concept Ltd delivers strong FY26 Growth
  • Gokaldas Exports consolidated FY26 Total Income up by 4% YoY
  • Trigyn Technologies Ltd - Result Highlights for Q4, FY26
  • Excelsoft Technologies Reports Strong Q4 & FY26 Performance

Keywords Selected:  HealthCanada

Stock Report

  • OneSource Supports Second Generic Semaglutide Approval in Canada
  • CuraTeQ Biologics Secures Health Canada NOC for Bevqolva™ Bevacizumab Biosimilar
  • OneSource's Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection
  • Biocon Receives Health Canada Approval of Bosaya™ and Vevzuo™, Biosimilars to Prolia® and Xgeva®
  • Zydus receives approval from Health Canada for Mesalamine suppositories
  • Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V., a Biosimilar to Stelara®
  • Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
  • Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 & 1 mg
  • Biocon Biologics receives Health Canada approval for Yesafili™
  • Lupin announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD
  • Bausch Health and Glenmark announce the approval of RYALTRIS® in Canada
  • Lupin receives Health Canada approval for Rymti®, biosimilar Etanercept

Latest Post

  • Bajaj Broking Weekly FII and DII Commentary for 23rd May 2026
  • TCC Concept Ltd delivers strong FY26 Growth
  • Gokaldas Exports consolidated FY26 Total Income up by 4% YoY
  • Trigyn Technologies Ltd - Result Highlights for Q4, FY26
  • Excelsoft Technologies Reports Strong Q4 & FY26 Performance


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025